More potent antiplatelet agents — such as clopidogrel (
Plavix),
prasugrel (Effient), and others currently in the pipeline — could have an even stronger effect against fibrosis, said Athan Kuliopulos, MD, PhD, professor of medicine at the Tufts University Sackler School of Biomedical Sciences in Boston, who was not involved with the study.
"And this is just liver fibrosis," he told Medscape Medical News. "What does it mean for outcome?